Amedica (AMDA) Competitors

Amedica (NASDAQ:AMDA) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, community ranking, earnings and media sentiment.

Is AMDA or PDEX more profitable?

Pro-Dex has a net margin of 11.06% compared to Amedica's net margin of -139.62%. Pro-Dex's return on equity of 21.68% beat Amedica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amedica	-139.62%	-148.60%	-67.83%
Pro-Dex	11.06%	21.68%	12.40%

Which has more risk and volatility, AMDA or PDEX?

Amedica has a beta of -1.24, meaning that its stock price is 224% less volatile than the S&P 500. Comparatively, Pro-Dex has a beta of 0.37, meaning that its stock price is 63% less volatile than the S&P 500.

Does the media refer more to AMDA or PDEX?

In the previous week, Pro-Dex had 2 more articles in the media than Amedica. MarketBeat recorded 2 mentions for Pro-Dex and 0 mentions for Amedica. Pro-Dex's average media sentiment score of 1.26 beat Amedica's score of 0.00 indicating that Pro-Dex is being referred to more favorably in the news media.

Company	Overall Sentiment
Amedica	Neutral
Pro-Dex	Positive

Do institutionals & insiders have more ownership in AMDA or PDEX?

3.7% of Amedica shares are owned by institutional investors. Comparatively, 15.3% of Pro-Dex shares are owned by institutional investors. 0.9% of Amedica shares are owned by insiders. Comparatively, 47.5% of Pro-Dex shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Does the MarketBeat Community prefer AMDA or PDEX?

Amedica received 151 more outperform votes than Pro-Dex when rated by MarketBeat users. Likewise, 64.90% of users gave Amedica an outperform vote while only 61.90% of users gave Pro-Dex an outperform vote.

Company	Underperform	Outperform
Amedica	Outperform Votes 307 64.90%	Underperform Votes 166 35.10%
Pro-Dex	Outperform Votes 156 61.90%	Underperform Votes 96 38.10%

Which has higher earnings and valuation, AMDA or PDEX?

Pro-Dex has higher revenue and earnings than Amedica. Amedica is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amedica	$11.23M	2.97	-$9.32M	-$3.13	-0.90
Pro-Dex	$64.12M	2.32	$2.13M	$2.80	16.29

Do analysts recommend AMDA or PDEX?

Pro-Dex has a consensus price target of $52.00, indicating a potential upside of 13.99%. Given Pro-Dex's stronger consensus rating and higher probable upside, analysts clearly believe Pro-Dex is more favorable than Amedica.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amedica	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Pro-Dex	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Pro-Dex beats Amedica on 15 of the 18 factors compared between the two stocks.